BRPI0924012A2 - processo para obtenção de uma composição rica em ácidos graxos ômega 3 de um óleo de origem marinha, com um teor de af interior 90 mg/g composição, suplemento nutricional produto alimentar, composição farmacêutica, e, uso de um composto - Google Patents

processo para obtenção de uma composição rica em ácidos graxos ômega 3 de um óleo de origem marinha, com um teor de af interior 90 mg/g composição, suplemento nutricional produto alimentar, composição farmacêutica, e, uso de um composto

Info

Publication number: BRPI0924012A2
Authority: BR; Brazil
Prior art keywords: composition; omega; obtaining; oil; interior
Prior art date: 2009-04-17

Application number

BRPI0924012A

Other languages

English (en)

Inventor

Manuel Cela Lopes Jose

Original Assignee

Cela Vista Pharmaceuticals Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-04-17

Filing date

2009-04-17

Publication date

2019-09-24

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41279300&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0924012(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2009-04-17 Application filed by Cela Vista Pharmaceuticals Ltd filed Critical Cela Vista Pharmaceuticals Ltd

2019-09-24 Publication of BRPI0924012A2 publication Critical patent/BRPI0924012A2/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
- C11C1/00—Preparation of fatty acids from fats, fatty oils, or waxes; Refining the fatty acids
- C11C1/02—Preparation of fatty acids from fats, fatty oils, or waxes; Refining the fatty acids from fats or fatty oils
- C11C1/025—Preparation of fatty acids from fats, fatty oils, or waxes; Refining the fatty acids from fats or fatty oils by saponification and release of fatty acids
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/52—Adding ingredients
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
- C11C1/00—Preparation of fatty acids from fats, fatty oils, or waxes; Refining the fatty acids
- C11C1/08—Refining
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
- C11C3/00—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
- C11C3/02—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fatty acids with glycerol
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Oncology (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Oil, Petroleum & Natural Gas (AREA)
Ophthalmology & Optometry (AREA)
Wood Science & Technology (AREA)
Physical Education & Sports Medicine (AREA)
Nutrition Science (AREA)
Diabetes (AREA)
Pulmonology (AREA)
Microbiology (AREA)
Hematology (AREA)
Heart & Thoracic Surgery (AREA)
Polymers & Plastics (AREA)
Molecular Biology (AREA)
Food Science & Technology (AREA)
Orthopedic Medicine & Surgery (AREA)
Cardiology (AREA)
Neurology (AREA)
Rheumatology (AREA)
Obesity (AREA)
Neurosurgery (AREA)
Tropical Medicine & Parasitology (AREA)
Mycology (AREA)
Biomedical Technology (AREA)

BRPI0924012A 2009-04-17 2009-04-17 processo para obtenção de uma composição rica em ácidos graxos ômega 3 de um óleo de origem marinha, com um teor de af interior 90 mg/g composição, suplemento nutricional produto alimentar, composição farmacêutica, e, uso de um composto BRPI0924012A2 (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/EP2009/002842 WO2010118761A1 (en)	2009-04-17	2009-04-17	Compositions rich in omega-3 fatty acids with a low content in phytanic acid

Publications (1)

Publication Number	Publication Date
BRPI0924012A2 true BRPI0924012A2 (pt)	2019-09-24

Family

ID=41279300

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0924012A BRPI0924012A2 (pt)	2009-04-17	2009-04-17	processo para obtenção de uma composição rica em ácidos graxos ômega 3 de um óleo de origem marinha, com um teor de af interior 90 mg/g composição, suplemento nutricional produto alimentar, composição farmacêutica, e, uso de um composto

Country Status (14)

Country	Link
US (1)	US9062275B2 (pt)
EP (1)	EP2429317B2 (pt)
JP (1)	JP5872453B2 (pt)
KR (1)	KR101759353B1 (pt)
CN (1)	CN102438468B (pt)
AU (1)	AU2009344374B2 (pt)
BR (1)	BRPI0924012A2 (pt)
CA (1)	CA2756528A1 (pt)
DK (1)	DK2429317T4 (pt)
ES (1)	ES2574136T5 (pt)
MX (1)	MX2011010821A (pt)
PL (1)	PL2429317T5 (pt)
PT (1)	PT2429317T (pt)
WO (1)	WO2010118761A1 (pt)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPWO2012067224A1 (ja) *	2010-11-19	2014-05-19	日本水産株式会社	角膜上皮障害及び／又は結膜上皮障害の治療又は予防剤
MX348898B (es)	2011-01-25	2017-07-03	Nestec Sa	Métodos y composiciones para tratar, reducir, o prevenir el deterioro del sistema visual de los animales.
US20120252888A1 (en) *	2011-03-29	2012-10-04	Palupa Medical Ltd.	Compositions and Methods for Treating Neurologic Disorders
CN102747045B (zh) *	2011-04-19	2013-12-18	华中农业大学	一种猪流感h1n1亚型灭活疫苗及制备方法
HRP20151039T1 (hr)	2011-09-12	2015-11-20	Tassos GEORGIOU	Upotreba omega masnih kiselina za lijeäśenje bolesti
PE20142459A1 (es)	2012-01-06	2015-01-23	Omthera Pharmaceuticals Inc	Composiciones enriquecidas con dpa de acidos grasos omega 3 poliinsaturados en forma de acido libre
US20160228397A1 (en)	2012-03-30	2016-08-11	Sancilio & Company, Inc.	Omega-3 fatty acid ester compositions
HK1204978A1 (zh)	2012-03-30	2015-12-11	桑茨利奥&孔帕尼股份有限公司	ω-3脂肪酸酯组合物
US10898458B2 (en)	2012-03-30	2021-01-26	Micelle Biopharma, Inc.	Self-micellizing fatty acids and fatty acid ester compositions and their use in the treatment of disease states
US9480651B2 (en)	2012-03-30	2016-11-01	Sancilio & Company, Inc.	Omega-3 fatty acid ester compositions unitary pharmaceutical dosage forms
KR20150028233A (ko)	2012-05-07	2015-03-13	옴테라 파마슈티칼스, 인크.	스타틴 및 오메가-３ 지방산의 조성물
EP4342537A3 (en) *	2012-09-12	2024-07-03	Novaliq GmbH	Semifluorinated alkane compositions
EP3100722B1 (en)	2012-09-12	2024-03-20	Novaliq GmbH	Semifluorinated alkanes for use in solubilizing meibum
WO2014085486A2 (en)	2012-11-30	2014-06-05	Waters Technologies Corporation	Methods and apparatus for the analysis of vitamin d metabolites
ITMI20130354A1 (it)	2013-03-08	2014-09-09	Again Life Italia Srl	Miscela di acidi grassi (f.a.g. fatty acids group) per uso nel trattamento di patologie infiammatorie.
WO2014138987A1 (en)	2013-03-14	2014-09-18	UNIVERSITé LAVAL	Use of electroretinography (erg) for the assessment of psychiatric disorders
WO2014143806A1 (en) *	2013-03-15	2014-09-18	The Penn State Research Foundation	Acid stable liposomal compositions
PL2991507T3 (pl) *	2013-04-22	2020-02-28	Smartfish As	Zastosowanie kompozycji zawierającej olej rybny i sok do leczenia i/lub po leczeniu nowotworu
AU2014343900A1 (en) *	2013-10-28	2016-03-17	Nestec S.A.	Monoacylglycerols and fat-soluble nutrients for use in the treatment of malabsorption having a non-mechanical basis
EP2881456A1 (en) *	2013-12-04	2015-06-10	Natac Pharma, S.L.	Enzymatic method for separating phytanic acid from fats or oils containing it and recovering unaltered products free of phytanic acid
PL3082795T3 (pl) *	2013-12-19	2020-11-16	Tassos GEORGIOU	Kompozycje kwasów tłuszczowych omega 3 w leczeniu chorób, które powodują uszkodzenie systemu nerwowego
EP3943081A1 (en) *	2014-03-13	2022-01-26	Retrotope, Inc.	Optic neuropathy treatment and reduction of steroid- induced oxidative stress with stabilized polyunsaturated substances
WO2015165507A1 (en) *	2014-04-29	2015-11-05	Georgiou Tassos	Treatment of eye diseases using omega 3 fatty acids and aa/epa blood ratio
JP2016141624A (ja) *	2015-01-30	2016-08-08	有限会社ハヌマット	癌患者の予後改善剤
EP3273954B1 (en)	2015-03-26	2020-10-28	Tiberio Bruzzese	Purified compositions of polyunsaturated fatty acids, their preparation method and their use
CN107922885A (zh)	2015-08-31	2018-04-17	日本水产株式会社	含游离多元不饱和脂肪酸组合物及其制造方法
DE202016008738U1 (de)	2015-09-30	2019-04-09	Novaliq Gmbh	Semifluorierte Verbindungen und ihre Zusammensetzungen
JPWO2017094804A1 (ja) *	2015-12-01	2018-09-13	日本水産株式会社	ドコサヘキサエン酸含有油及びその製造方法
EP3430403A4 (en) *	2016-03-15	2019-08-14	Biomerica Inc.	COMPOSITIONS, DEVICES AND METHODS FOR TESTING SENSITIVITY IN FIBROMYALGIA
KR20180051737A (ko) *	2016-11-08	2018-05-17	차의과학대학교 산학협력단	대장염-관련 암 발생을 줄이는 ω-3 폴리불포화지방산 활성 성분으로 포함하는 항암 조성물
RU2652342C1 (ru) *	2017-07-13	2018-04-25	Наталья Александровна Гаврилова	Композиция для лечения ретинальной неоваскуляризации в эксперименте и способ лечения с ее использованием
CN119909046A (zh)	2017-10-04	2025-05-02	诺瓦利克有限责任公司	包含f6h8的眼用组合物
CN108096181A (zh) *	2018-02-05	2018-06-01	西安医学院	Dha、epa在制备治疗干眼症的口服药物的应用
CN112153970A (zh)	2018-04-27	2020-12-29	诺瓦利克有限责任公司	用于治疗青光眼的包含他氟前列素的眼用组合物
CN112823020A (zh)	2018-10-12	2021-05-18	诺瓦利克有限责任公司	用于治疗干眼病的眼用组合物
JP7608707B2 (ja) *	2019-02-25	2025-01-07	株式会社坪田ラボ	近視進行抑制剤、機能性食品及び眼科用組成物
SG10201902000YA (en) *	2019-03-06	2020-10-29	Nat Univ Singapore	Isthmin 1 for treatment of lung inflammation
KR20210016746A (ko)	2019-08-05	2021-02-17	충남대학교산학협력단	오메가-3 불포화 지방산을 포함하는 항톡소포자충 조성물
JP2022544847A (ja) *	2019-08-21	2022-10-21	バークアンドボイヤー、インコーポレイテッド	一価不飽和脂肪酸組成物及び脂肪性肝疾患を治療するための使用
CN110846346B (zh) *	2019-11-26	2021-06-22	瞿瀚鹏	富含Sn-2位DHA的微生物油脂及其制备方法和应用
EP4128270A4 (en)	2020-03-26	2024-04-03	Diamentis Inc.	SYSTEMS AND METHODS FOR PROCESSING RETINAL SIGNAL DATA AND IDENTIFYING CONDITIONS
KR20210018171A (ko)	2020-11-16	2021-02-17	충남대학교산학협력단	오메가-3 지방산으로의 전환을 유도하는 Caenorhabditis elegans fat-1효소를 포함하는 항톡소포자충 조성물
US20240165075A1 (en) *	2021-02-08	2024-05-23	Synaptogenix, Inc.	Treatment of optic nerve inflammation using pkc activators
CN113584093B (zh) *	2021-07-30	2022-07-19	江南大学	一种高dha含量的结构脂质的制备方法及其产品
CN113995747A (zh) *	2021-10-19	2022-02-01	杭州莱樱斯生物医药科技有限公司	一种治疗脱发的产品及银杏内酯a在治疗应激诱发脱发的新用途
US20250151997A1 (en)	2022-02-09	2025-05-15	Diamentis Inc.	Systems and methods for retinal stimulation and/or collecting retinal signal data

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5697503A (en) *	1980-01-07	1981-08-06	Nippon Oil & Fats Co Ltd	Separation of constituent component from mixed composition of plural component of org. compound
JPS57149400A (en) *	1981-03-12	1982-09-14	Kureha Chemical Ind Co Ltd	Manufacture of high purity long chain highly unsaturated fatty acid ester
US4792418A (en) *	1985-08-14	1988-12-20	Century Laboratories, Inc.	Method of extraction and purification of polyunsaturated fatty acids from natural sources
EP0347509A1 (en)	1988-06-21	1989-12-27	Century Laboratories Inc.	A process of extraction and purification of polyunsaturated fatty acids from natural sources
IT1205043B (it)	1987-05-28	1989-03-10	Innova Di Ridolfi Flora & C S	Procedimento per l'estrazione di esteri di acidi grassi poliinsaturi da olii di pesce e composizioni farmaceutiche e dietetiche contenenti detti esteri
US4843095A (en)	1987-08-07	1989-06-27	Century Laboratories, Inc.	Free fatty acids for treatment or propyhlaxis of rheumatoid arthritis arthritis
US5023100A (en)	1988-05-02	1991-06-11	Kabi Vitrum Ab	Fish oil
US4874629A (en)	1988-05-02	1989-10-17	Chang Stephen S	Purification of fish oil
JPH0225447A (ja) *	1988-07-13	1990-01-26	Nippon Oil & Fats Co Ltd	高度不飽和脂肪酸類の製造方法
GB8819110D0 (en)	1988-08-11	1988-09-14	Norsk Hydro As	Antihypertensive drug & method for production
DK190689D0 (da)	1989-04-19	1989-04-19	Novo Industri As	Omestringsproces
US5013569A (en)	1990-05-21	1991-05-07	Century Laboratories, Inc.	Infant formula
SE9303446D0 (sv)	1993-10-20	1993-10-20	Trikonex Ab	A novel urea fractionation process
CN1105205A (zh)	1994-01-11	1995-07-19	黄升	富含dha和活性钙的补脑益智营养食品及其制备方法
ES2131129T3 (es)	1994-05-09	1999-07-16	Nestle Sa	Procedimiento para la preparacion de un concentrado de esteres de acidos grasos poliinsaturados.
JPH0898659A (ja)	1994-09-30	1996-04-16	Nippon Suisan Kaisha Ltd	ストレスに対する改善効果を有する魚類用飼料
CN1130040A (zh)	1995-12-05	1996-09-04	杨学斌	一种含dha的健脑膨化食品
GB2350610A (en)	1999-06-01	2000-12-06	Jfs Envirohealth Ltd	Preparation of pure unsaturated fatty acids
CA2311974A1 (en)	1999-06-28	2000-12-28	Nisshin Flour Milling Co., Ltd.	Processes of selectively separating and purifying eicosapentaenoic and docosahexaenoic acids or their esters
US7226916B1 (en) *	2000-05-08	2007-06-05	N.V. Nutricia	Preparation for the prevention and/or treatment of vascular disorders
JP4530311B2 (ja) †	2000-07-13	2010-08-25	日本水産株式会社	リパーゼを用いたグリセライドの製造方法
CN1345544A (zh) *	2000-09-29	2002-04-24	国家海洋药物工程技术研究中心	海洋产物营养保健蛋的生产方法
NL1019368C2 (nl) *	2001-11-14	2003-05-20	Nutricia Nv	Preparaat voor het verbeteren van receptorwerking.
CN1378846A (zh) *	2002-03-22	2002-11-13	海南加华海产生物制药有限公司	鲨鱼肝油胶丸
JP4771697B2 (ja) *	2002-09-24	2011-09-14	サントリーホールディングス株式会社	認知能力の正常応答の低下予防、改善又は向上作用を有する組成物
US6846942B2 (en)	2003-05-20	2005-01-25	David Rubin	Method for preparing pure EPA and pure DHA
CN1245169C (zh)	2004-01-29	2006-03-15	任连坤	一种提高记忆力、改善认知的纯天然复合制剂及其制备方法
CN101018862B (zh) *	2004-04-22	2013-10-09	联邦科学技术研究组织	用重组细胞合成长链多不饱和脂肪酸
NZ555394A (en) *	2004-11-19	2010-07-30	Martek Biosciences Corp	Oxylipins from long chain polyunsaturated fatty acids including docosapentaenoic acid and docosatetraenoic acid (DPA and DTA) and methods of making and using the same
CN101213281B (zh) *	2005-05-04	2013-03-13	普罗诺瓦生物医药挪威公司	新的dha衍生物及其作为药物的用途
BRPI0613358A8 (pt) *	2005-07-08	2017-12-26	Dsm Ip Assets Bv	ácidos de gordura poli - insaturada para o tratamento da demência e condições relacionadas à pré-demência
ITMI20051560A1 (it) *	2005-08-10	2007-02-11	Tiberio Bruzzese	Composizione di acidi grassi n-3 con elevata concentrazione di epa e-o dha e contenente acidi grassi n-6
US20070166411A1 (en) *	2005-12-16	2007-07-19	Bristol-Myers Squibb Company	Nutritional supplement containing long-chain polyunsaturated fatty acids
CA2632949C (en) *	2005-12-21	2012-05-22	Brudy Technology, S.L.	Use of dha, epa or dha-derived epa for treating a pathology associated with cellular oxidative damage
ES2277557B1 (es)	2005-12-21	2008-07-01	Proyecto Empresarial Brudy, S.L.	Utilizacion de acido docosahexaenoico para el tratamiento del daño celular oxidativo.
WO2007091070A1 (en) *	2006-02-07	2007-08-16	Universitetet I Oslo	Omega 3
US8003813B2 (en) *	2006-06-27	2011-08-23	Pos Pilot Plant Corporation	Process for separating saturated and unsaturated fatty acids
US7550614B2 (en)	2006-11-13	2009-06-23	Rohm And Haas Company	Method for esterification of free fatty acids in triglycerides
KR100832397B1 (ko) *	2007-02-12	2008-05-26	경북대학교 산학협력단	디아실글리세롤함유 식용유지의 제조방법
CN100574772C (zh) *	2007-03-23	2009-12-30	童宥霖	一种含叶黄素的软胶囊及其制备方法
US20080268117A1 (en)	2007-04-30	2008-10-30	David Rubin	Method of purifying oils containing epa and dha
WO2009020406A1 (en) *	2007-08-07	2009-02-12	Granate Seed Limited	Methods of making lipid substances, lipid substances made thereby and uses thereof
CN101381298B (zh) *	2008-10-21	2011-09-07	四川省毛叶山桐子科技股份有限公司	利用毛叶山桐子油制备共轭亚油酸的方法
WO2011018096A1 (en) *	2009-08-10	2011-02-17	K.D. Pharma Bexbach Gmbh	Phytanic acid fractionation process, fatty acid products and use thereof

2009
- 2009-04-17 MX MX2011010821A patent/MX2011010821A/es active IP Right Grant
- 2009-04-17 WO PCT/EP2009/002842 patent/WO2010118761A1/en not_active Ceased
- 2009-04-17 PL PL09776547T patent/PL2429317T5/pl unknown
- 2009-04-17 BR BRPI0924012A patent/BRPI0924012A2/pt not_active IP Right Cessation
- 2009-04-17 US US13/264,659 patent/US9062275B2/en active Active
- 2009-04-17 CA CA2756528A patent/CA2756528A1/en not_active Abandoned
- 2009-04-17 KR KR1020117027108A patent/KR101759353B1/ko active Active
- 2009-04-17 EP EP09776547.3A patent/EP2429317B2/en active Active
- 2009-04-17 PT PT97765473T patent/PT2429317T/pt unknown
- 2009-04-17 DK DK09776547.3T patent/DK2429317T4/da active
- 2009-04-17 ES ES09776547T patent/ES2574136T5/es active Active
- 2009-04-17 AU AU2009344374A patent/AU2009344374B2/en active Active
- 2009-04-17 CN CN200980158786.7A patent/CN102438468B/zh active Active
- 2009-04-17 JP JP2012505054A patent/JP5872453B2/ja active Active

Also Published As

Publication number	Publication date
CN102438468B (zh)	2014-06-04
AU2009344374A1 (en)	2011-10-27
US9062275B2 (en)	2015-06-23
EP2429317B1 (en)	2016-03-30
PT2429317T (pt)	2016-07-22
US20120053242A1 (en)	2012-03-01
EP2429317B2 (en)	2019-02-20
JP5872453B2 (ja)	2016-03-01
KR101759353B1 (ko)	2017-07-18
CA2756528A1 (en)	2010-10-21
PL2429317T5 (pl)	2019-09-30
ES2574136T3 (es)	2016-06-15
JP2012523823A (ja)	2012-10-11
CN102438468A (zh)	2012-05-02
DK2429317T4 (da)	2019-05-13
MX2011010821A (es)	2012-01-20
PL2429317T3 (pl)	2016-09-30
WO2010118761A1 (en)	2010-10-21
DK2429317T3 (en)	2016-07-18
KR20120039521A (ko)	2012-04-25
EP2429317A1 (en)	2012-03-21
ES2574136T5 (es)	2019-08-30
AU2009344374B2 (en)	2015-07-23

Publication	Publication Date	Title
BRPI0924012A2 (pt)	2019-09-24	processo para obtenção de uma composição rica em ácidos graxos ômega 3 de um óleo de origem marinha, com um teor de af interior 90 mg/g composição, suplemento nutricional produto alimentar, composição farmacêutica, e, uso de um composto
BRPI0919192A2 (pt)	2015-08-18	Uso de lipídio, composição nutricional, e, processo para a produção de uma composição nutricional
BRPI0915149A2 (pt)	2015-08-04	Composição nutricional, e usos de uma composição, e de um produto derivado de leite
BRPI0914023A2 (pt)	2016-07-26	composição nutricional e método para fornecer uma nutrição
PT2445355T (pt)	2017-08-16	Recipiente para um dispositivo para a preparação de uma confeitaria congelada e dispositivo para a preparação de uma confeitaria congelada
BRPI0820981A2 (pt)	2014-10-14	Conversão microbiana de óleos e ácidos graxos para substâncias químicas de valor elevado
BR112013015284A2 (pt)	2016-07-19	produtos de confeitaria à base de geleia que apresentam uma mistura de estabilizador/fibra
CL2012002897A1 (es)	2014-04-11	Metodo que comprende procesar biomasa microbiana interrumpida no tratada que tiene una composicion de aceite y fraccionar el extracto obtenido para obtener una composicion lipidica de al menos un acido graso poliinsaturado.
BR112014019927A8 (pt)	2018-01-16	fórmula nutricional, método de preparação da referida fórmula antes da sua ingestão por um indivíduo, uso da referida fórmula, dispositivo para prepará-la e recipiente
WO2013049519A3 (en)	2014-05-08	Compositions, kits and methods for nutritional supplementation with twelve carbon chain fatty acids and twelve carbon chain acylglycerols
BRPI0819732A2 (pt)	2016-07-26	produtos de carne com níveis aumentados de ácidos graxos benéficos
BRPI1010651A2 (pt)	2015-09-15	método para a preparação de produtos à base de carne contendo óleo que compreendem uma quantidade reduzida de aditivos e produtos obteníveis a partir do referido método.
EP2443936A3 (en)	2014-04-16	Method for reducing the saturated fatty acid content of milk fat, products obtained and applications thereof.
BRPI0917942A2 (pt)	2015-08-18	Óleo contendo um ou mais fosfolipídeos de ácidos graxos poli-insaturados de cadeia longa derivados de biomassa.
BRPI0917779A2 (pt)	2015-08-18	Produto alimentício e método para enriquecer um produto alimentício e utilização de um produto alimentício
BR112012014938A2 (pt)	2015-08-25	Composições de sabor de maillard com solventes polares diferentes de água e métodos para produzir tais composições
BR112013007239A2 (pt)	2016-06-14	''composição de chocolate aerado e processo para fabricação de uma composição de chocolate aerado''.
BRPI0811788A2 (pt)	2014-10-07	Composição de proteína vegetal, processo para a fabricação de uma composição de proteína vegetal e produto alimentício
BR112012013541A8 (pt)	2015-10-13	composição de gordura, composição nutricional líquida para alimentação por sonda, uso da composição nutricional líquida, uso de uma composição de gordura, método para prover nutrição enteral a uma pessoa que necessita desta
BRPI0812935A2 (pt)	2015-08-25	Processo para a criação de uma composição de suplemento alimentar nutritiva animal
HUE056170T2 (hu)	2022-01-28	Cisz egyszeresen telítetlen zsírsavak alfa származékai gyógyszerekként való alkalmazásra
IL219958A0 (en)	2012-07-31	Omega-3 fatty acid enriched meat compositions
BR112012005852A2 (pt)	2019-09-24	composição antioxidante, gênero alimentício, processo para a prevenção e/ou inibição da oxidação de um gênero alimentício, uso e kit para a preparação de uma composição
CO6791566A2 (es)	2013-11-14	Uso de composiciones nutricionales que incluyen lactoferrina para respaldar la resistencia a enfermedadesy estados patológicos
BR112012024214A2 (pt)	2019-09-24	método para melhorar a palatabilidade de composições comestíveis.

Legal Events

Date	Code	Title	Description
2019-10-01	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
2020-01-21	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.